We are live on ! Find out more
QC

Quantedge Capital Portfolio holdings

AUM $183M
1-Year Est. Return 37.27%
This Fund
S&P 500
This Quarter Est. Return
+20.02%
1 Year Est. Return
+37.27%
3 Year Est. Return
+101.13%
5 Year Est. Return
+161.06%
10 Year Est. Return
AUM
$183M
AUM Growth
+$73.5M
Cap. Flow
+$63.5M
Cap. Flow %
34.78%
Top 10 Hldgs %
66.21%
Holding
92
New
30
Increased
13
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
PVH icon
PVH
PVH
+$24.3M
2
ADNT icon
Adient
ADNT
+$24.2M
3
HLF icon
Herbalife
HLF
+$18.1M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$7.02M
5
BLBD icon
Blue Bird Corp
BLBD
+$6.95M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 41.4%
2 Consumer Staples 16.82%
3 Healthcare 15.78%
4 Industrials 11.85%
5 Communication Services 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
26
Ascendis Pharma A/S
ASND
$16B
$1.41M 0.77%
+7,100
New +$1.32M
GDV icon
27
Gabelli Dividend & Income Trust
GDV
$2.6B
$1.41M 0.77%
51,941
-75,300
-59% -$2.01M
TWN
28
Taiwan Fund
TWN
$471M
$1.27M 0.7%
23,484
-13,553
-37% -$663K
AMPH icon
29
Amphastar Pharmaceuticals
AMPH
$879M
$1.2M 0.66%
+45,100
New +$1.16M
FIGS icon
30
FIGS
FIGS
$1.79B
$1.14M 0.62%
170,200
VRSN icon
31
VeriSign
VRSN
$26.2B
$1.12M 0.61%
4,000
BTX
32
BlackRock Technology and Private Equity Term Trust
BTX
$940M
$1.04M 0.57%
155,329
+142,600
+1,120% +$1.02M
NBXG
33
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.16B
$976K 0.53%
63,462
-90,100
-59% -$1.34M
KYN icon
34
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$968K 0.53%
78,294
-156,300
-67% -$1.93M
TNK icon
35
Teekay Tankers
TNK
$2.75B
$955K 0.52%
+18,900
New +$896K
STOK icon
36
Stoke Therapeutics
STOK
$1.8B
$940K 0.51%
+40,000
New +$685K
ANIP icon
37
ANI Pharmaceuticals
ANIP
$1.8B
$824K 0.45%
9,000
-2,900
-24% -$236K
RMT
38
Royce Micro-Cap Trust
RMT
$728M
$658K 0.36%
63,297
-25,400
-29% -$251K
BBW icon
39
Build-A-Bear
BBW
$425M
$600K 0.33%
+9,200
New +$542K
ALNY icon
40
Alnylam Pharmaceuticals
ALNY
$27.5B
$593K 0.32%
+1,300
New +$529K
KNSA icon
41
Kiniksa Pharmaceuticals
KNSA
$5.8B
$584K 0.32%
+15,045
New +$489K
CAF
42
Morgan Stanley China A Share Fund
CAF
$322M
$544K 0.3%
32,662
-21,921
-40% -$326K
DVAX
43
DELISTED
Dynavax Technologies
DVAX
$525K 0.29%
+52,900
New +$551K
GAM
44
General American Investors Company
GAM
$1.56B
$524K 0.29%
8,417
-9,400
-53% -$554K
EVER icon
45
EverQuote
EVER
$892M
$510K 0.28%
+22,300
New +$539K
RVT icon
46
Royce Value Trust
RVT
$2.21B
$500K 0.27%
31,000
+16,400
+112% +$258K
WOR icon
47
Worthington Enterprises
WOR
$2.75B
$461K 0.25%
8,300
-16,000
-66% -$1.01M
TDF
48
Templeton Dragon Fund
TDF
$270M
$460K 0.25%
39,516
-19,300
-33% -$207K
MSM icon
49
MSC Industrial Direct
MSM
$6.89B
$451K 0.25%
+4,900
New +$437K
REVG
50
DELISTED
REV Group
REVG
$402K 0.22%
+7,100
New +$377K

Similar funds

Quantedge Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Quantedge Capital held 92 positions worth $183M, up 67% from $109M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Quantedge Capital deployed $63.5M of net new capital in Q3 2025, opening 30 new positions and adding to 13 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 25,800 shares worth $7.23M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 41% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was DNOW Inc, an estimated $5.42M trimmed.

  • Quantedge Capital's largest Q3 2025 buy was Bio-Rad Laboratories Class A: 25,800 shares worth $7.23M.
  • Quantedge Capital added most to PVH in Q3 2025, an estimated $24.3M increase.
  • Quantedge Capital's biggest Q3 2025 reduction was DNOW Inc, cutting an estimated $5.42M.
  • Quantedge Capital fully exited Columbia Sportswear in Q3 2025, selling an estimated $7.37M.
  • Quantedge Capital's ten largest holdings make up 66% of its $183M portfolio in Q3 2025.
  • Quantedge Capital opened 30 new positions and closed 24 in Q3 2025.
  • Quantedge Capital's portfolio value rose 67% quarter-over-quarter to $183M.

Based on Quantedge Capital's 13F filing for Q3 2025, filed 14 Nov 2025.